Cargando…

Integrins as attractive targets for cancer therapeutics

Integrins are transmembrane receptors that have been implicated in the biology of various human physiological and pathological processes. These molecules facilitate cell–extracellular matrix and cell–cell interactions, and they have been implicated in fibrosis, inflammation, thrombosis, and tumor me...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Meng, Wang, Ying, Li, Mengwei, Wu, Xuezhen, Setrerrahmane, Sarra, Xu, Hanmei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8463276/ https://www.ncbi.nlm.nih.gov/pubmed/34589393 http://dx.doi.org/10.1016/j.apsb.2021.01.004

Ejemplares similares

Trends in insulin resistance: insights into mechanisms and therapeutic strategy
por: Li, Mengwei, et al.
Publicado: (2022)

Tumor-related interleukins: old validated targets for new anti-cancer drug development
por: Setrerrahmane, Sarra, et al.
Publicado: (2017)

Micropeptide MIAC inhibits the tumor progression by interacting with AQP2 and inhibiting EREG/EGFR signaling in renal cell carcinoma
por: Li, Mengwei, et al.
Publicado: (2022)

Novel production method of innovative antiangiogenic and antitumor small peptides in Escherichia coli
por: Setrerrahmane, Sarra, et al.
Publicado: (2017)

Accurate control of dual-receptor-engineered T cell activity through a bifunctional anti-angiogenic peptide
por: Zhang, Erhao, et al.
Publicado: (2018)

Combination Therapy of PEG-HM-3 and Methotrexate Retards Adjuvant-Induced Arthritis
por: Hao, Jingchao, et al.
Publicado: (2017)

BET Proteins as Attractive Targets for Cancer Therapeutics
por: Sarnik, Joanna, et al.
Publicado: (2021)

mTOR: An attractive therapeutic target for osteosarcoma?
por: Ding, Liu, et al.
Publicado: (2016)

Integrins as Therapeutic Targets: Successes and Cancers
por: Raab-Westphal, Sabine, et al.
Publicado: (2017)

Integrin Targeted Therapeutics
por: Millard, Melissa, et al.
Publicado: (2011)

Receptor tyrosine kinase inhibitor Sunitinib and integrin antagonist peptide HM-3 show similar lipid raft dependent biphasic regulation of tumor angiogenesis and metastasis
por: Hu, Jialiang, et al.
Publicado: (2019)

Integrin Targeted Delivery of Gene Therapeutics
por: Juliano, Rudy L, et al.
Publicado: (2011)

Retraction Note: Receptor tyrosine kinase inhibitor Sunitinib and integrin antagonist peptide HM-3 show similar lipid raft dependent biphasic regulation of tumor angiogenesis and metastasis
por: Hu, Jialiang, et al.
Publicado: (2020)

Proteoglycans Are Attractive Biomarkers and Therapeutic Targets in Hepatocellular Carcinoma
por: Tanaka, Yasuo, et al.
Publicado: (2018)

Rewired Metabolism Caused by the Oncogenic Deregulation of MYC as an Attractive Therapeutic Target in Cancers
por: Vízkeleti, Laura, et al.
Publicado: (2023)

Nrf2 Is an Attractive Therapeutic Target for Retinal Diseases
por: Nakagami, Yasuhiro
Publicado: (2016)

Integrins regulate stemness in solid tumor: an emerging therapeutic target
por: Xiong, Jiangling, et al.
Publicado: (2021)

Integrin signaling in cancer: bidirectional mechanisms and therapeutic opportunities
por: Li, Siyi, et al.
Publicado: (2023)

Cancer testis antigen subfamilies: Attractive targets for therapeutic vaccine (Review)
por: Ren, Shengnan, et al.
Publicado: (2023)

Non-coding RNA regulation of integrins and their potential as therapeutic targets in cancer
por: Verhoeff, Tristan Joseph, et al.
Publicado: (2022)

Targeting TMEM88 as an Attractive Therapeutic Strategy in Malignant Tumors
por: Cai, Ming, et al.
Publicado: (2022)

Inflammatory Cytokine: An Attractive Target for Cancer Treatment
por: Lee, Hyang-Mi, et al.
Publicado: (2022)

Shedding New Light on The Role of ανβ3 and α5β1 Integrins in Rheumatoid Arthritis
por: Morshed, Arwa, et al.
Publicado: (2019)

Coronavirus helicases: attractive and unique targets of antiviral drug-development and therapeutic patents
por: Spratt, Austin N., et al.
Publicado: (2021)

Role of gut microbiome in cancer immunotherapy: from predictive biomarker to therapeutic target
por: Zhang, Mengwei, et al.
Publicado: (2023)

The complexity of integrins in cancer and new scopes for therapeutic targeting
por: Hamidi, Hellyeh, et al.
Publicado: (2016)

Protein Kinase C: An Attractive Target for Cancer Therapy
por: Marengo, Barbara, et al.
Publicado: (2011)

Integrins and cadherins as therapeutic targets in fibrosis
por: Agarwal, Sandeep K.
Publicado: (2014)

Integrins as Therapeutic Targets for Respiratory Diseases
por: Teoh, C.M., et al.
Publicado: (2016)

Integrins as therapeutic targets in the organ-specific metastasis of human malignant melanoma
por: Huang, Ruixia, et al.
Publicado: (2018)

Platelet Integrins in Tumor Metastasis: Do They Represent a Therapeutic Target?
por: Lavergne, Marion, et al.
Publicado: (2017)

Platelet integrin αIIbβ3: signal transduction, regulation, and its therapeutic targeting
por: Huang, Jiansong, et al.
Publicado: (2019)

Targeting Integrins in Cancer Nanomedicine: Applications in Cancer Diagnosis and Therapy
por: Wu, Ping-Hsiu, et al.
Publicado: (2019)

Targeting Glutamine Metabolism as an Attractive Therapeutic Strategy for Acute Myeloid Leukemia
por: Xiao, Yan, et al.
Publicado: (2023)

BCL-2 protein family: attractive targets for cancer therapy
por: Kaloni, Deeksha, et al.
Publicado: (2022)

β1 Integrins as Therapeutic Targets to Disrupt Hallmarks of Cancer
por: Blandin, Anne-Florence, et al.
Publicado: (2015)

Interleukin-17 regulation: an attractive therapeutic approach for asthma
por: Park, Seoung Ju, et al.
Publicado: (2010)

Integrin Targeted Delivery of Radiotherapeutics
por: Liu, Zhaofei, et al.
Publicado: (2011)

Integrin-Linked Kinase Is a Novel Therapeutic Target in Ovarian Cancer
por: Ulm, Michael A., et al.
Publicado: (2020)

Integrin Inhibitors as a Therapeutic Agent for Ovarian Cancer
por: Sawada, Kenjiro, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_0g5oi112c5hlmb062231faqcjt